Kymera Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $605.9M
Liabilities Breakdown FY2021
Total Liabilities: $146.3M
Asset Breakdown
Total Assets: $605.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $48.0M | 7.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $11.9M | 2.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $546.0M | 90.1% |
Liabilities Breakdown
Total Liabilities: $146.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.0M | 2.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $142.3M | 97.3% |